ArcBest beat fourth-quarter expectations Friday but noted that continued industrial weakness is weighing on its results.

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

Q4 2024 Earnings Call Transcript January 29, 2025 Corning Incorporated beats earnings expectations. Reported EPS is $0.57, ...

Elon Musk claimed this week that Tesla robotaxi's will hit the roads this summer however skepticism from industry experts and ...

Blackstone Inc. (NYSE:BX) reported stronger-than-expected earnings for the fourth quarter of 2024, with earnings per share ...

Despite a challenging year marked by labor disputes and revenue declines, Canadian National Railway Co (CNI) outlines a ...

KONE Oyj (KNYJF) reports strong service and modernization growth, while navigating headwinds in the Chinese market.

Getinge AB (GNGBF) reports robust sales growth and strategic restructuring amid market challenges and quality-related costs.

Tesla Q4 earnings call's high-level weirdness, including the impact Bitcoin had on the bottom line, what it means for stock prices.

The credit card issuer's earnings missed Wall Street estimates, but it reported improvement in sales, delinquencies and ...

Apple reported $18.5 billion in sales in greater China last quarter, comfortably below consensus estimates of $20.9 billion.

Meta CEO Mark Zuckerberg teased a "return to OG Facebook" as part of his key goals for 2025 in Wednesday's Q4 earnings call ...